Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon…

Global refugee crises often evoke varying levels of public sympathy, with some displaced groups receiving a warmer welcome than others.…

Following a new U.S. green light for some ovarian cancer patients, Corcept Therapeutics has redeemed its lead asset, Lilacolilant, after…

Ionis Pharmaceuticals is slashing the price of its expected blockbuster drug, Tringolza (olesarsen), in preparation for expanding the drug’s reach…

A new bill in California continues the state’s efforts to crack down on ultra-processed foods, proposing that manufacturers put a…